2-amino-5-phosphonovalerate has been researched along with 2'-deoxyadenosine triphosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyce, S; Clark, NC; Huber, I; Jarolimek, W; Kuenzi, FM; Kullmann, DM; Nagano, N; Seabrook, GR; Striessnig, J; Walter, D; Wietzorrek, G | 1 |
1 other study(ies) available for 2-amino-5-phosphonovalerate and 2'-deoxyadenosine triphosphate
Article | Year |
---|---|
Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels.
Topics: Animals; Behavior, Animal; Binding Sites; Body Weight; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Case-Control Studies; Deoxyadenine Nucleotides; Dose-Response Relationship, Drug; Drinking; Ear; Eating; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; Immunohistochemistry; In Situ Hybridization; Isotope Labeling; Isradipine; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neurons; Oligonucleotide Probes; Pain Threshold; Phenotype; Rats; Rotation; Synapses; Time Factors; Valine | 2003 |